These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33767660)

  • 1. A Novel Pathogenic
    Lin PY; Hung JH; Hsu CK; Chang YT; Sun YT
    Front Neurol; 2021; 12():632336. PubMed ID: 33767660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel splice site HSPG2 mutation and prenatal diagnosis in Schwartz Jampel Syndrome type 1 using whole exome sequencing.
    Das Bhowmik A; Dalal A; Matta D; Kandadai RM; Kanikannan MA; Aggarwal S
    Neuromuscul Disord; 2016 Nov; 26(11):809-814. PubMed ID: 27521129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Schwartz-Jampel Syndrome with Botulinum Toxin Type A.
    Suphatsathienkul P; Sakpichaisakul K; Wechapinan T; Trachoo O; Virawan S; Wanitphakdeedecha R
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):545-556. PubMed ID: 38285320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and genetic features of Schwartz-Jampel syndrome in a Chinese child: case report and literature review].
    Dai L; Fang F; Huang Y; Cheng H; Ren C
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):855-9. PubMed ID: 26758326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
    Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
    Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).
    Nicole S; Davoine CS; Topaloglu H; Cattolico L; Barral D; Beighton P; Hamida CB; Hammouda H; Cruaud C; White PS; Samson D; Urtizberea JA; Lehmann-Horn F; Weissenbach J; Hentati F; Fontaine B
    Nat Genet; 2000 Dec; 26(4):480-3. PubMed ID: 11101850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding genetic and clinical aspects of Schwartz-Jampel syndrome: A report of two cases with literature review.
    Elahi Vahed I; Tehrani Fateh S; Kamali M; Hashemi-Gorji F; Esmaeilzadeh Z; Sadeghi H; Miryounesi M; Ghasemi MR
    Mol Genet Metab Rep; 2024 Sep; 40():101125. PubMed ID: 39157536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel HSPG2 Gene Mutation Causing Schwartz-Jampel Syndrome in a Moroccan Family: A Literature Review.
    Brugnoni R; Marelli D; Iacomino N; Canioni E; Cappelletti C; Maggi L; Ardissone A
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.
    Echaniz-Laguna A; Rene F; Marcel C; Bangratz M; Fontaine B; Loeffler JP; Nicole S
    Muscle Nerve; 2009 Jul; 40(1):55-61. PubMed ID: 19367640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Human-Induced Pluripotent Stem Cells Derived from a Patient with Schwartz-Jampel Syndrome Revealed Distinct Hyperexcitability in the Skeletal Muscles.
    Yamashita Y; Nakada S; Nakamura K; Sakurai H; Ohno K; Goto T; Mabuchi Y; Akazawa C; Hattori N; Arikawa-Hirasawa E
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space.
    Iwata S; Ito M; Nakata T; Noguchi Y; Okuno T; Ohkawara B; Masuda A; Goto T; Adachi M; Osaka H; Nonaka R; Arikawa-Hirasawa E; Ohno K
    Neuromuscul Disord; 2015 Aug; 25(8):667-71. PubMed ID: 26031903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome.
    Martinez JR; Grindel BJ; Hubka KM; Dodge GR; Farach-Carson MC
    J Cell Biochem; 2019 Feb; 120(2):2138-2150. PubMed ID: 30203597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schwartz-Jampel syndrome with gastroduodenal bleeding.
    Polat İ; Karaoğlu P; Yiş U; Kurul SH
    J Pediatr Neurosci; 2016; 11(3):255-257. PubMed ID: 27857801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.
    Arikawa-Hirasawa E; Le AH; Nishino I; Nonaka I; Ho NC; Francomano CA; Govindraj P; Hassell JR; Devaney JM; Spranger J; Stevenson RE; Iannaccone S; Dalakas MC; Yamada Y
    Am J Hum Genet; 2002 May; 70(5):1368-75. PubMed ID: 11941538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modular Proteoglycan Perlecan/
    Martinez JR; Dhawan A; Farach-Carson MC
    Genes (Basel); 2018 Nov; 9(11):. PubMed ID: 30453502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation.
    Gürbüz G; Albayrak HM
    Turk J Pediatr; 2019; 61(6):967-970. PubMed ID: 32134596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel HSPG2 mutations causing Schwartz‑Jampel syndrome type 1 in a Chinese family: A case report.
    Yan W; Dai J; Shi D; Xu X; Han X; Xu Z; Chen D; Teng H; Jiang Q
    Mol Med Rep; 2018 Aug; 18(2):1761-1765. PubMed ID: 29901129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients.
    Farshadyeganeh P; Yamada T; Ohashi H; Nishimura G; Fujita H; Oishi Y; Nunode M; Ishikawa S; Murotsuki J; Yamashita Y; Ikegawa S; Ogi T; Arikawa-Hirasawa E; Ohno K
    J Hum Genet; 2024 Jun; 69(6):235-244. PubMed ID: 38424183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schwartz-Jampel Syndrome Type-1: Compound Heterozygosity of Two Novel Variants.
    Atmaca FG; Akgün Doğan Ö; Kutlubay B; Kırmızıbekmez H
    J Clin Res Pediatr Endocrinol; 2024 Jan; ():. PubMed ID: 38212959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schwartz-Jampel syndrome and perlecan deficiency.
    Stum M; Davoine CS; Fontaine B; Nicole S
    Acta Myol; 2005 Oct; 24(2):89-92. PubMed ID: 16550923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.